| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/07/2004 | EP1404659A1 4-aryl quinols and analogs thereof as therapeutic agents |
| 04/07/2004 | EP1404657A1 Pyridazinone |
| 04/07/2004 | EP1404656A1 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases |
| 04/07/2004 | EP1404654A2 Calcilytic compounds |
| 04/07/2004 | EP1404653A1 Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion |
| 04/07/2004 | EP1404652A1 A novel alkaloid derivative and a pharmaceutical composition containing the same |
| 04/07/2004 | EP1404650A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 04/07/2004 | EP1404649A1 New phenylalkyloxy-phenyl derivatives |
| 04/07/2004 | EP1404648A1 Amidine substituted aryl and heteroaryl derivatives with an antithrombotic and factor xa inhibiting action |
| 04/07/2004 | EP1404644A2 Novel hydrazones |
| 04/07/2004 | EP1404641A1 Crystalline form of a phenylethanolamine, the preparation thereof and pharmaceutical compositions comprising the same |
| 04/07/2004 | EP1404516A2 Microencapsulation of drugs by solvent exchange |
| 04/07/2004 | EP1404413A2 Dermatological formulations |
| 04/07/2004 | EP1404374A1 Slc2as as modifiers of the p53 pathway and methods of use |
| 04/07/2004 | EP1404369A1 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases |
| 04/07/2004 | EP1404365A2 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 04/07/2004 | EP1404359A2 Methods of treatment involving human mda-7 |
| 04/07/2004 | EP1404356A2 Cd10-activated prodrug compounds |
| 04/07/2004 | EP1404353A2 Methods of using a hyaluronan receptor |
| 04/07/2004 | EP1404352A1 Environmentally safe insect repellent composition |
| 04/07/2004 | EP1404351A1 Carbohydrate modifying agent and drinks containing the modifying agent |
| 04/07/2004 | EP1404349A1 Fat-binding polymers |
| 04/07/2004 | EP1404348A2 Compositions and methods for decreasing the risk of or preventing neural tube disorders in mammals |
| 04/07/2004 | EP1404347A2 4'-substituded nucleosides for the treatment of diseases mediated by the hepatitis c virus |
| 04/07/2004 | EP1404346A2 Calcium phosphate delivery vehicles for osteoinductive proteins |
| 04/07/2004 | EP1404345A2 Skin-permeable selective cyclooxygenase-2 inhibitor composition |
| 04/07/2004 | EP1404344A2 Bone anabolic compounds and methods of use |
| 04/07/2004 | EP1404343A2 Therapeutic combinations for the treatment of hormone deficiencies |
| 04/07/2004 | EP1404342A1 Treatment of psychotic disorders comprising co-therapy with anticonvulsant derivatives and atypical antipsychotics |
| 04/07/2004 | EP1404341A1 Active substance combination for medicamentous therapy of nicotine dependency |
| 04/07/2004 | EP1404340A1 Naphtothiazine positive allosteric ampa receptor modulators (paarm) |
| 04/07/2004 | EP1404339A2 Method for treating fibrotic diseases or other indications vi |
| 04/07/2004 | EP1404338A1 Adenosine analogues for the treatment of the insulin resistance syndrome and diabetes |
| 04/07/2004 | EP1404337A2 QUINAZOLINE AND PYRIDO 2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
| 04/07/2004 | EP1404336A1 Compositions comprising cgmppde5 inhibitor for transdermal delivery to the erectile tissue of the penis |
| 04/07/2004 | EP1404335A1 Amino nicotinate derivatives as glucokinase (glk) modulators |
| 04/07/2004 | EP1404334A1 Targeted delivery of bioaffecting compounds for the treatment of cancer |
| 04/07/2004 | EP1404333A1 Oxymorphone controlled release formulations |
| 04/07/2004 | EP1404332A1 Methods of making sustained release formulations of oxymorphone related applications |
| 04/07/2004 | EP1404331A1 Sustained release formulations of oxymorphone |
| 04/07/2004 | EP1404330A1 Substituted 8-arylquinoline pde4 inhibitors |
| 04/07/2004 | EP1404329A1 Substituted 4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1h)-quinolinones and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 04/07/2004 | EP1404328A1 Alpha-hydroxyamide statine derivatives for the treatment of alzheimer's disease |
| 04/07/2004 | EP1404327A2 Dermatological composition comprising nicotinic acid or an amide, and a sphingoid base |
| 04/07/2004 | EP1404326A2 Method of treating parkinson's disease |
| 04/07/2004 | EP1404325A2 Method for treating nerve injury caused by surgery |
| 04/07/2004 | EP1404324A2 Prodrugs of gaba analogs, compositions and uses thereof |
| 04/07/2004 | EP1404323A1 Use of methylnaltrexone to treat immune suppression |
| 04/07/2004 | EP1404322A2 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof |
| 04/07/2004 | EP1404321A1 1-alkyl-2-aryl-benzimidazole derivatives, their use for producing medicaments and pharmaceutical preparations containing said derivatives |
| 04/07/2004 | EP1404320A2 A pharmaceutical composition comprising a nicotinic receptor partial antagonist and an antiemetic agent for modulating cholinergic function |
| 04/07/2004 | EP1404319A1 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy |
| 04/07/2004 | EP1404318A2 Compounds and methods for regulating cell differentiation |
| 04/07/2004 | EP1404317A1 5-halo-tryptamine derivatives used as ligands of the 5-ht 6? and/or 5-ht 7? serotonin receptors |
| 04/07/2004 | EP1404316A1 Cycloalkylpyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives as gaba-a receptor ligands |
| 04/07/2004 | EP1404315A1 Synergistic compositions of n-acylhomoserine lactones and 4-quinolones |
| 04/07/2004 | EP1404314A1 Aerosol formulations of delta 8 tetrahydrocannabinol |
| 04/07/2004 | EP1404313A2 METHYL ANALOGS OF SIMVASTATIN AS NOVEL HMG-CoA REDUCTASE INHIBITORS |
| 04/07/2004 | EP1404312A1 Carbamate compounds for use in the treatment of pain |
| 04/07/2004 | EP1404311A1 Wound treatment agent |
| 04/07/2004 | EP1404310A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
| 04/07/2004 | EP1404309A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- 4-(2- 4-methane sulfonyl oxyphenyl ethoxy) phenyl] propanoic acid or 3- 4- 2- (4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl -(s)-2-ethoxy propanoic acid and a biguanide drug |
| 04/07/2004 | EP1404308A1 Treatment of disorders secondary to organic impairments |
| 04/07/2004 | EP1404307A2 Estrogen receptor-related receptor alpha (err) agonist for inducing cartilage formation |
| 04/07/2004 | EP1404306A1 A coated nicotine-containing chewing gum, manufacture and use thereof |
| 04/07/2004 | EP1404304A1 Tablet comprising cetirizine and pseudoephedrine |
| 04/07/2004 | EP1404303A1 Stable pharmaceutical compositions containing pravastatin |
| 04/07/2004 | EP1404302A1 Pharmaceutical compositions of adsorbates of amorphous drug |
| 04/07/2004 | EP1404301A2 Stable controlled release pharmaceutical compositions containing pravastatin |
| 04/07/2004 | EP1404300A1 Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| 04/07/2004 | EP1404299A2 Particles for inhalation having rapid release properties |
| 04/07/2004 | EP1404291A1 Water-free ubichinon concentrate |
| 04/07/2004 | EP1404281A1 Pharmaceutical compositions of topic use, applied in treatment of skin and/or mucous injuries; use of compositions in treatment of skin and/or mucous injuries and use of compounds in treatment of skin and/or mucous injuries |
| 04/07/2004 | EP1404174A2 Anti-infective compositions for treating disordered tissue such as cold sores |
| 04/07/2004 | EP1317459B1 Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 04/07/2004 | EP1317238A4 Compositions containing a vitamin c component and pigment |
| 04/07/2004 | EP1307457B1 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 04/07/2004 | EP1303282A4 Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides |
| 04/07/2004 | EP1303267B1 Dermal for amino laevulinic acid |
| 04/07/2004 | EP1296662B1 Dermal therapeutic system containing 2-(3-benzophenyl)-propionic acid or '0-(2,6-dichloranilino)-phenyl!-ethanoic acid |
| 04/07/2004 | EP1292299B1 New use of citreamicins |
| 04/07/2004 | EP1240132B1 Adamantane derivatives |
| 04/07/2004 | EP1226133B1 N-SUBSTITUTED 3-AMINO-2,2-DI-C-ALKYL-1,4-BUTYROLACTONES AND 1,4-THIOBUTYROLACTONES FOR USE AS PROMOTER OF $g(g)-AMINOBUTYRIC ACID ACTIVITY AND FOR TREATING NERVOUS DISORDERS AND PREPARATION METHOD |
| 04/07/2004 | EP1220699B1 Medicament pack |
| 04/07/2004 | EP1196046B1 Composition for the prevention of muscle fatigue and skeletal muscle adaptation to strenuous exercise |
| 04/07/2004 | EP1185272B1 Novel use of 1-[4-(5-cyanoindol-3yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine and its physiological acceptable salts for the treatment of bipolar disorders and mania |
| 04/07/2004 | EP1183043B1 Medicament for localised application, containing fibrinogen, thrombin, transglutaminases and proteinase inhibitors |
| 04/07/2004 | EP1182204B1 Crystals of carbapenem derivatives and pharmaceutical preparations for injection |
| 04/07/2004 | EP1171110B1 Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis |
| 04/07/2004 | EP1156806B1 Pharmaceutical composition containing proton pump inhibitors |
| 04/07/2004 | EP1150991B1 Compositions for treating inflammatory response |
| 04/07/2004 | EP1149087B1 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use |
| 04/07/2004 | EP1147773B1 Medicinal compositions for treating osseous lesion in multiple myeloma |
| 04/07/2004 | EP1137424B1 Preparation which contains oligosaccharides and probiotics |
| 04/07/2004 | EP1128820B1 Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 04/07/2004 | EP1105401B1 Phosphoglycolipid and methods for its use |
| 04/07/2004 | EP1105123B1 Pharmaceutical compositions containing lipase inhibitors and chitosan |
| 04/07/2004 | EP1089970B1 Oxidation inhibitors for prostane derivatives |
| 04/07/2004 | EP1086077B1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application |
| 04/07/2004 | EP1085907B1 Solution comprising prostaglandins and benzyl alcohol |